News
Adrenomed AG is translating the concept of precision medicine to acute care with a biomarker-guided antibody therapy for sepsis and septic shock. With a mortality rate of 20–30% in developed ...
A 23-year-old medical student from Jersey has had all four limbs amputated after her flu-like symptoms turned into septic shock. In January, Lily McGarry woke up with a sore throat and a cough but ...
The following is a summary of “Early high-dose vasopressors in refractory septic shock: A cohort study,” published in the ...
Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...
The company’s lead compound, nangibotide, is a first-in-class anti-TREM-1 peptide and is currently in phase 2 trials for septic shock. An excessive immune response is often responsible for the ...
do not support the use of G-CSF as an adjunct therapy to standard care for critically ill patients with severe sepsis or septic shock. Data from prospective, large, randomized, controlled ...
She said the amputations were because the sepsis and septic shock caused Ms McGarry's blood pressure to drop so low that it shut off all blood supply to her limbs. Ms Jennings said the aim of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results